ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search


CurrentAll Trials


Trial Details

Comparative Health Research Outcomes of Novel Surgery in Prostate Cancer

Design and Objective

Two linked open label, multicentre RCTs with choice of A or B dependent on physician and patient equipoise. CHRONOS-A: Two arm RCT to evaluate progression free survival rates of Focal Therapy (FT) compared to radical therapy (radiotherapy or surgery) in prostate cancer treatment. CHRONOS-B: Multi-Arm Multi-Stage RCT to evaluate failure free survival rates of FT alone compared to FT combined with other therapies.

Key inclusion criteria

Men over 18 years old with a diagnosis of medium risk prostate cancer or low risk cancer proven on biopsy. Participants should have an interest in undergoing Focal Therapy as a treatment for prostate cancer and be fit to undergo Radical Therapy or Focal Therapy without any previous prostate cancer treatments.

Study Disclaimer Statement